Which term best describes nalbuphine's action that prevents other opioids from binding?

Which term best describes nalbuphine's action that prevents other opioids from binding?

• A. competitive agonist
• B. noncompetitive antagonist
• C. irreversible antagonist
• D. competitive antagonist

Answer: (D)

The main idea here is how drugs interact with receptors when they share the same binding site. Nalbuphine blocks mu opioid receptors by occupying the same site that other opioids would use, and it does so reversibly. This makes it a competitive antagonist: it prevents other opioids from binding by competing for the same receptor site, and its blockade can be overcome by higher concentrations of the competing opioid. Because the binding is reversible, you’d see a rightward shift in the dose–response curve for another opioid without reducing the maximum effect that nalbuphine itself can achieve. It’s not an agonist at the mu receptor, since its role here is to prevent activation by others, not to activate the receptor. It’s also not a noncompetitive or irreversible antagonist, which would involve binding at a different site or causing permanent receptor inactivation and would reduce the maximum effect regardless of agonist concentration. So the term that fits best is competitive antagonist.

The main idea here is how drugs interact with receptors when they share the same binding site. Nalbuphine blocks mu opioid receptors by occupying the same site that other opioids would use, and it does so reversibly. This makes it a competitive antagonist: it prevents other opioids from binding by competing for the same receptor site, and its blockade can be overcome by higher concentrations of the competing opioid.

Because the binding is reversible, you’d see a rightward shift in the dose–response curve for another opioid without reducing the maximum effect that nalbuphine itself can achieve. It’s not an agonist at the mu receptor, since its role here is to prevent activation by others, not to activate the receptor. It’s also not a noncompetitive or irreversible antagonist, which would involve binding at a different site or causing permanent receptor inactivation and would reduce the maximum effect regardless of agonist concentration. So the term that fits best is competitive antagonist.